Top Analyst Upgrades & Downgrades (ARNA, BJ, BP, CEDC, GRMN, NVS, NVDA, PT)

Investing

Published: July 2, 2010 8:44 am

Last Updated: April 28, 2020 8:23 am

The number of analyst calls ahead of the three-day weekend are fairly small, as you would expect. Some of this Friday’s top analyst research calls with upgrades, downgrades, and initiations seen from Wall Street firms are as follows:

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) Raised To Outperform at Leerink Swann.
BJ’s Wholesale Club Inc. (NYSE: BJ) Raised to Neutral at Goldman Sachs.
BP plc (NYSE: BP) Maintained Buy but target cut to $41 at Benchmark.
Central European Distribution Corp. (NASDAQ: CEDC) Raised to Overweight at JPMorgan.
Garmin Ltd. (NASDAQ: GRMN) Cut to Underperform at Bank of America/Merrill Lynch.
Novartis AG (NYSE: NVS) Raised to Buy at Soc-Gen.
NVIDIA Corp. (NASDAQ: NVDA) Cut targets by Needham.
Portugal Telecom SA (NYSE: PT) Raised to Buy at Citigroup.

JON C. OGG

In 20 Years, I Haven’t Seen A Cash Back Card This Good

After two decades of reviewing financial products I haven’t seen anything like this. Credit card companies are at war, handing out free rewards and benefits to win the best customers.

A good cash back card can be worth thousands of dollars a year in free money, not to mention other perks like travel, insurance, and access to fancy lounges.

Our top pick today pays up to 5% cash back, a $200 bonus on top, and $0 annual fee. Click here to apply before they stop offering rewards this generous.

Flywheel Publishing has partnered with CardRatings for our coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.